This 12-week trial will compare individuals receiving naltrexone or placebo plus substance
abuse counseling therapy versus those receiving only substance abuse counseling therapy in a
rural, nonacademic setting. A followup period of 12 months is included. The effect on service
utilization and the cost of the addition of naltrexone to treatment services for alcohol
dependence also will be assessed. The study will expand existing research concerning the
effectiveness of naltrexone in clinical trials versus a clinical setting.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)